176 related articles for article (PubMed ID: 27470583)
1. ACER3 supports development of acute myeloid leukemia.
Chen C; Yin Y; Li C; Chen J; Xie J; Lu Z; Li M; Wang Y; Zhang CC
Biochem Biophys Res Commun; 2016 Sep; 478(1):33-38. PubMed ID: 27470583
[TBL] [Abstract][Full Text] [Related]
2. ADCY7 supports development of acute myeloid leukemia.
Li C; Xie J; Lu Z; Chen C; Yin Y; Zhan R; Fang Y; Hu X; Zhang CC
Biochem Biophys Res Commun; 2015 Sep; 465(1):47-52. PubMed ID: 26220344
[TBL] [Abstract][Full Text] [Related]
3. Alkaline ceramidase 3 promotes growth of hepatocellular carcinoma cells via regulating S1P/S1PR2/PI3K/AKT signaling.
Yin Y; Xu M; Gao J; Li M
Pathol Res Pract; 2018 Sep; 214(9):1381-1387. PubMed ID: 30097213
[TBL] [Abstract][Full Text] [Related]
4. SPG6 supports development of acute myeloid leukemia by regulating BMPR2-Smad-Bcl-2/Bcl-xl signaling.
Chen J; Li C; Zhan R; Yin Y
Biochem Biophys Res Commun; 2018 Jun; 501(1):220-225. PubMed ID: 29715457
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
[TBL] [Abstract][Full Text] [Related]
6. Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis.
Hu W; Xu R; Sun W; Szulc ZM; Bielawski J; Obeid LM; Mao C
J Biol Chem; 2010 Mar; 285(11):7964-76. PubMed ID: 20068046
[TBL] [Abstract][Full Text] [Related]
7. Elevated SH3BP5 Correlates with Poor Outcome and Contributes to the Growth of Acute Myeloid Leukemia Cells.
Li M; Hao S; Li C; Xiao H; Sun L; Yu Z; Zhang N; Xiong Y; Zhao D; Yin Y
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31546831
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.
Wen D; Xiao H; Gao Y; Zeng H; Deng J
Mol Cancer; 2024 May; 23(1):116. PubMed ID: 38822351
[TBL] [Abstract][Full Text] [Related]
9. BEX1 acts as a tumor suppressor in acute myeloid leukemia.
Lindblad O; Li T; Su X; Sun J; Kabir NN; Levander F; Zhao H; Lu G; Rönnstrand L; Kazi JU
Oncotarget; 2015 Aug; 6(25):21395-405. PubMed ID: 26046670
[TBL] [Abstract][Full Text] [Related]
10. SHIP1 is targeted by miR-155 in acute myeloid leukemia.
Xue H; Hua LM; Guo M; Luo JM
Oncol Rep; 2014 Nov; 32(5):2253-9. PubMed ID: 25175984
[TBL] [Abstract][Full Text] [Related]
11. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells.
Xu L; Zhang Y; Gao M; Wang G; Fu Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060
[TBL] [Abstract][Full Text] [Related]
12. Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.
Hartman AD; Wilson-Weekes A; Suvannasankha A; Burgess GS; Phillips CA; Hincher KJ; Cripe LD; Boswell HS
Exp Hematol; 2006 Oct; 34(10):1360-76. PubMed ID: 16982329
[TBL] [Abstract][Full Text] [Related]
13. Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells.
Liang H; Zheng QL; Fang P; Zhang J; Zhang T; Liu W; Guo M; Robinson CL; Chen SB; Chen XP; Chen FP; Zeng H
Sci Rep; 2017 Jan; 7():40361. PubMed ID: 28098170
[TBL] [Abstract][Full Text] [Related]
14. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
[TBL] [Abstract][Full Text] [Related]
15. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia.
Zeng Z; Samudio IJ; Zhang W; Estrov Z; Pelicano H; Harris D; Frolova O; Hail N; Chen W; Kornblau SM; Huang P; Lu Y; Mills GB; Andreeff M; Konopleva M
Cancer Res; 2006 Apr; 66(7):3737-46. PubMed ID: 16585200
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of GLUT3 Promotes Apoptosis and Chemosensitivity of Acute Myeloid Leukemia Cells via EGFR Signaling.
Zhuang Y; Zhao J; Xu X; Bi L
Arch Iran Med; 2018 Feb; 21(2):73-78. PubMed ID: 29664658
[TBL] [Abstract][Full Text] [Related]
18. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.
Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M
Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294
[TBL] [Abstract][Full Text] [Related]
19. SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model.
Täger M; Horn S; Latuske E; Ehm P; Schaks M; Nalaskowski M; Fehse B; Fiedler W; Stocking C; Wellbrock J; Jücker M
Gene Ther; 2017 Nov; 24(11):749-753. PubMed ID: 29143813
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation.
Tao YF; Li ZH; Du WW; Xu LX; Ren JL; Li XL; Fang F; Xie Y; Li M; Qian GH; Li YH; Li YP; Li G; Wu Y; Feng X; Wang J; He WQ; Hu SY; Lu J; Pan J
Oncol Rep; 2017 Mar; 37(3):1419-1429. PubMed ID: 28184925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
